目的探讨原发性醛固酮增多症(原醛症)患者代谢综合征(MS)的患病率情况。方法收集2000年1月—2011年1月我院诊治的110例原醛患者的临床资料并进行回顾性统计,分析该人群中MS的患病情况。结果原醛患者MS患病率为50.9%;在MS各组分中,高血压、为糖代谢紊乱(糖调节受损+糖尿病)、体重超重或肥胖、高甘油三酯血症(TG)、低高密度脂蛋白胆固醇(HDL)检出率分别为90.1%、34.5%、23.6%、20.1%、9.0%。结论原醛症患者有较高的MS发病率,一旦确诊,应进行积极治疗,以降低代谢异常而增加心血管事件发生的风险。 Objective To investigate the prevalence of metabolic syndrome (MS) in patients with primary aldosteronism (primary aldosteronism). Methods The clinical data of 110 patients with primary aldosteronism diagnosed and treated in our hospital from January 2000 to January 2011 were collected and retrospectively analyzed to analyze the prevalence of MS in this population. Results The prevalence of MS in patients with primary aldehyde was 50.9%. Among the various components of MS, hypertension was caused by disorders of glucose metabolism (impaired glucose regulation and diabetes mellitus), overweight or obesity, hypertriglyceridemia (TG) The detection rates of low-density lipoprotein cholesterol (HDL) were 90.1%, 34.5%, 23.6%, 20.1% and 9.0%, respectively. Conclusions Primary aldosteronism patients have higher incidence of MS. Once diagnosed, active treatment should be carried out to reduce the metabolic abnormalities and increase the risk of cardiovascular events.